A paradigm shift in molecular biology has set in. It is now possible to email a DNA sequence to a company and receive a recombinant plasmid vector of choice. We are soon heading into an era where ...

Recombinant DNA (rDNA) refers to artificial DNA molecules that are created by combining genetic material from different sources. This technology involves the insertion of DNA fragments from one ...

Success in gene and cell therapy is driving demand for plasmid DNA which is a key reagent to produce viral vectors, both for commercial products as well as the breadth of different vectors for the ...

North America dominated the viral vector & plasmid DNA manufacturing market with a revenue share in 2024. Asia Pacific is expected to grow at the fastest CAGR in the market during the forecast period.

- EffiX™ is designed to meet the industry's demand for a high-yield, stable, and non-lysogenic E. coli expression system. It serves as a comprehensive solution for the development and manufacturing of ...

Background. Human immunodeficiency virus (HIV) vaccine development remains a global priority. We describe the safety and immunogenicity of a multiclade DNA vaccine prime with a replication-defective ...

New York, June 23, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Viral Vector & Plasmid DNA Manufacturing Market by Type, Workflow, Application, Diseases, End User - ...

New York, June 24, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Viral Vectors And Plasmid DNA Manufacturing Market Size, Share & Trends Analysis Report By Vector Type ...

Although efficiency of adenovirus vector creation by homologous recombination in 293 cells was improved by a green/white selection process, 17 the initial isolates still consist of mixtures of ...

Recombinant DNA, which is often shortened to rDNA, is an artificially made DNA strand that is formed by the combination of two or more gene sequences. This new combination may or may not occur ...